Status:
AVAILABLE
Glioblastoma and Individualized Therapies
Lead Sponsor:
Zentrum fur Humangenetik Tuebingen
Conditions:
Glioma, Malignant
Eligibility:
All Genders
Brief Summary
The treatment of patients with World Health Organization (WHO) grade 4 malignant glioma has not seen any significant breakthrough the past years. Following surgery and radio / chemotherapy patients st...
Eligibility Criteria
Inclusion
- malignant glioma, IDH WT
Exclusion
- na
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05356312
Last Update
March 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zentrum für Humangenetik Tübingen
Tübingen, Germany